We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant Patients

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: October 4, 2005
Last Update Posted: April 24, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Prof. Philip Halloran, Edmonton, Canada (sponsor)
Prof. Yves Vanrenterghem, Leuven, Belgium (Steering Committee Member)
Prof. Pierre Daloze, Montréal, Canada (Steering Committee Member)
Prof. Thomas C. Pearson, Atlanta, USA (Steering Committee Member)
Prof. Ulrich Frei, Berlin, Germany (Steering Committee Member)
Prof. Flavio Vincenti, San Francisco, USA (Ass. Steering Committee Member)
Prof. Josep Grinyo, Barcelona, Spain (Ass. Steering Committee Member)
Hoffmann-La Roche
Information provided by:
Ekberg, Henrik, M.D.
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2008
  Primary Completion Date: May 2006 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):